"Cytokines in Cancer Immunotherapy"

September 13, 2019    


La Jolla Institute for Immunology

9420 Athena Circle, La Jolla, CA  92037


7:00am-8:00am  Breakfast and Networking

8:00am-10:00am  Presentations and Q&A

10:00am-10:30am  Break with Light Refreshments and Networking

10:30am-12:30pm  Presentations and Q&A

Kindly REGISTER by Friday, September 6, 2019.  Space is limited.


Confirmed Speakers (will be 5-6 total):

“Supercharging the Tumor Microenvironment with the Engineered Cytokines NKTR-214 and NKTR-255”

Loui Madakamutil, PhD
Nektar Therapeutics

Loui Madakamutil is currently SVP and Head of Preclinical development at Nektar Therapeutics and is responsible for the overall discovery strategy of Nektar to deliver novel immuno-modulatory medicines in several therapeutic areas including Cancer and Auto-inflammatory diseases. Previously Loui was a Senior Director and Lead for Rheumatology-DAS at Janssen Research Division where Loui was responsible for the discovery strategy and delivering portfolio assets from early ideas to proof of concept in humans in Rheumatic diseases. Loui held appointment as the Site Head of Immunology at Takeda Pharmaceuticals in San Diego, where he has held positions of increasing responsibility in Drug Discovery and Early Development, and was responsible for driving Takeda’s Discovery strategy in Immunology with a focus on inflammatory bowel disease (IBD) and Cancer Immunology. Loui also spent five years in Immunology discovery at Celgene in the Experimental Therapeutics Team where he worked on Apremilast and Revlemid to understand immunological MOA for these compounds. He has taken several large and small molecule compounds into Phase 1a. Loui did his Post-Doctoral training at the La Jolla Institute for Allergy and Immunology first with Eli Sercarz and then with Hilde Cheroutre. Loui has a PhD in applied immunology from University of Mumbai India and MS in Biochemistry.

“Plasmacytoid Dendritic Cell Exhaustion”

Elina Zuniga, PhD
UC San Diego Health

Elina Zuniga received her Biochemist degree (B.S./M.S. equivalent) from the National University of Cordoba, Argentina, where she received the “University Prize” of class 1994 (~1,500 students registered). This prize is the highest recognition given to the student with best grade point average in each class. She continued her education at the same institution where she obtained her Ph.D. in Biochemistry. Afterwards, Dr. Zuniga conducted postdoctoral research at The Scripps Research Institute where she held two post-doctoral fellowships from Antorchas Foundation and PEW Charitable Trust, respectively. After joining UCSD in 2007 she has received a Hellman Foundation Scholar Award, The Vilcek Finalist Prize for Creative Promise, the Leukemia and Lymphoma Society Scholar Award and the American Cancer Society Scholar Award (a lifetime honor). In 2018, the American Association of Immunologists also recognized her scientific achievements and exemplary career with the Vanguard Lecture.

Thank you to our Partners: